返回 
加入收藏
我院辅助用药合理管控的探索与实践
x
请在关注微信后，向客服人员索取文件
| 篇名： | 我院辅助用药合理管控的探索与实践 |
| TITLE： | |
| 摘要： | 目的：加强辅助用药的管控，促进医院合理用药。方法：介绍我院对辅助用药的管理措施；收集我院实施辅助用药管理前（2014年）、后（2015年）各季度的药品使用数据，采用SPSS 19.0统计软件，对两年的药占比、次均药品费用以及患者投诉例数等数据进行比较分析，评价管理效果。结果：通过加强对辅助用药的管理，包括明确辅助用药定义和标准，制订辅助用药目录并分类，采取削减采购量、医师培训、患者宣导、技术与行政干预等措施，我院辅助用药管理成效显著， 2014年与2015年的药占比分别约为45％、30％，次均住院药品费用分别约为2 000、1 400元，次均门诊药品费用分别约为250、180元，患者每季度投诉例数分别约为60、15例，差异均具有统计学意义（P＜0.05）。结论：加强辅助用药的管控，不仅能减少医院药品开支、减轻患者经济负担，还能促进医院合理用药、改善医患关系。但是，该项管理工作仍存在难点，目前尚缺乏行业政策与规范支撑，亟需国家卫生部门出台辅助用药管理的政策与技术规范。 |
| ABSTRACT： | OBJECTIVE： To strengthen the management and control of adjuvant drugs， and to improve the rational drug use. METHODS： The management measures of adjuvant drugs in our hospital were introduced. The data of drug use were collected from our hospital before （2014） and after （2015） adjuvant drugs management， and then analyzed statistically by SPSS 19.0 statistical software in respects of drug proportion， the per-visit drug expense and the number of patients’ complaints. The effects of management were evaluated. RESULTS： The adjuvant drugs management obtained significant achievement in our hospital through strengthening adjuvant drugs management， including confirming the definition and standard of adjuvant drugs， formulating adjuvant drugs list and classifying them， reducing purchase quantity， physician training， patient education， technological and administrative intervention， etc. The drug proportion had reduced from 45％ in 2014 to 35％ in 2015； per-visit inpatient drug expense had reduced from 2 000 yuan around to 1 400 yuan around； per-visit outpatient drug expense had reduced from 250 yuan around to 180 yuan around； the number of patients’ complaints had reduced from 60 around to 15 around in every season； the differences were statistically significant （P＜0.05）. CONCLUSIONS： The adjuvant drugs management and control can not only reduce the hospital’s expense and the patients burdens， but also enhance the rational drug use and improve the doctor-patient relationship. Nevertheless， there are some difficulties yet， on account of lacking of occupation policies and criteria. The national health department should publish the policies and the criteria of adjuvant drug management as soon as possible. |
| 期刊： | 2016年第27卷第31期 |
| 作者： | 唐哲，西娜 |
| AUTHORS： | TANG Zhe，XI Na |
| 关键字： | 辅助用药；管控；药占比；次均住院/门诊药品费用；患者投诉 |
| KEYWORDS： | Adjuvant drugs； Management and control； Drug proportion； Per-visit inpatient/outpatient drug expense； Patients’ complaints |
| 阅读数： | 389 次 |
| 本月下载数： | 22 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
